SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-23-122841
Filing Date
2023-12-01
Accepted
2023-12-01 16:16:44
Documents
1
Period of Report
2023-11-30

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2331921-2_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2331921-2_4seq1.xml 4 3999
  Complete submission text file 0001104659-23-122841.txt   5551
Mailing Address 300 PARK AVENUE 2ND FLOOR NEW YORK NY 10022
Business Address 300 PARK AVENUE 2ND FLOOR NEW YORK NY 10022 (646) 293-2100
SEELOS THERAPEUTICS, INC. (Issuer) CIK: 0001017491 (see all company filings)

IRS No.: 870449967 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 7 TURTLE CT FLEMINGTON NJ 08822
Business Address
Golembiewski Michael Joseph (Reporting) CIK: 0001639479 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-22245 | Film No.: 231459735